Age onsetClinical featuresHLA B27Acute Phase Reactants at onsetInitial treatmentFirst DMARDAnti-TNFRemission time prior to dosage reductionTotal time under anti-TNF dosage reduction
113Peripheral (polyarthritis, enthesitis, dactylitis)+raisedNSAID, steroidsmethotrexateetanercept579
214Mixed (olygoarthritis, sacroilitis)+raisedNSAID, steroid intrarticular injectionmethotrexateetanercept126
311Peripheral (enthesitis, monoarthritis)+normalNSAIDD, steroid intrarticular injectionSSZ, methotrexateetanercept246
411Mixed (olygoarthritis, sacroilitis)+normalNSAID, steroid intrarticular injectionmethotrexate, SSZadalimumab125